Postmarketing pharmacovigilance: Remdesivir and cardiovascular events COMMENT

Sullivan, JT

Sullivan, JT (通讯作者),78-7020 Mololani St, Kailua, HI 96740 USA.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022; 15 (4): 813

Abstract

Remdesivir was the first therapeutic approved for treatment of coronavirus disease 2019 (COVID-19). Food and Drug Administration (FDA) approval occurr......

Full Text Link